{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"AlphaNooner by AdvisorShares","title":"AlphaNooner - Canadian Cannabis Stocks: What Makes Cannara Biotech Different?","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/383ffa8b\"></iframe>","width":"100%","height":180,"duration":1583,"description":"Is Canadian cannabis entering a new phase of growth, and what separates the companies positioned to succeed? Cannara Biotech (TSX: LOVE | OTCQX: LOVFF) COO Niko Sosiak joins AdvisorShares AlphaNooner to discuss the outlook for Canadian cannabis stocks, Cannara's competitive advantage in Québec, and its strategy for scaling profitably. We explore the company's expanded $34 million supply agreement with Curaleaf, growing demand for premium cannabis products, opportunities for international expansion, and what U.S. cannabis rescheduling could mean for the broader industry. Plus, what should cannabis investors watch heading into 2027?\nAlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next.\nWatch the full video on YouTube: https://www.youtube.com/watch?v=A8Lgmv8dHfU\nFollow AdvisorShares (@advisorshares) on YouTube, X, LinkedIn, Instagram and Facebook.","thumbnail_url":"https://img.transistorcdn.com/YTg3I0tYDY_pVKIr6ftqR4QH-crMUIYU9Ptau8tTyEM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zOGUw/NDFhNmI0NGM3NGY5/OGU0ODBkZmNlOWMx/NjRjNy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}